Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Novanta (NOVT) EBITDA (2016 - 2025)

Historic EBITDA for Novanta (NOVT) over the last 17 years, with Q3 2025 value amounting to $21.8 million.

  • Novanta's EBITDA fell 3288.9% to $21.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $95.9 million, marking a year-over-year decrease of 915.83%. This contributed to the annual value of $110.6 million for FY2024, which is 7.96% up from last year.
  • According to the latest figures from Q3 2025, Novanta's EBITDA is $21.8 million, which was down 3288.9% from $14.9 million recorded in Q2 2025.
  • Over the past 5 years, Novanta's EBITDA peaked at $32.6 million during Q3 2024, and registered a low of $11.1 million during Q2 2021.
  • Moreover, its 5-year median value for EBITDA was $25.6 million (2024), whereas its average is $24.1 million.
  • As far as peak fluctuations go, Novanta's EBITDA skyrocketed by 11878.55% in 2022, and later plummeted by 4201.44% in 2025.
  • Quarter analysis of 5 years shows Novanta's EBITDA stood at $21.7 million in 2021, then rose by 23.77% to $26.8 million in 2022, then decreased by 19.25% to $21.7 million in 2023, then grew by 23.2% to $26.7 million in 2024, then fell by 18.19% to $21.8 million in 2025.
  • Its EBITDA was $21.8 million in Q3 2025, compared to $14.9 million in Q2 2025 and $32.4 million in Q1 2025.